Skip to main content
新赣江 logo

新赣江 — Investor Relations & Filings

Ticker · 920367 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2023-05-28 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920367

About 新赣江

http://www.xgjyy.com/

Jiangxi Xinganjiang Pharmaceutical Co., Ltd. specializes in the research, development, production, and distribution of a diverse range of pharmaceutical products. The company's portfolio encompasses chemical active pharmaceutical ingredients (APIs), chemical drug preparations, and traditional Chinese medicine (TCM) formulations. Its core product offerings target therapeutic areas such as cardiovascular and cerebrovascular health, digestive system disorders, and nutritional supplementation. Key products include Ginkgo Biloba extract, Vitamin C, and various gastrointestinal medications. By maintaining an integrated value chain that spans from raw material synthesis to finished dosage forms, the company ensures quality control and supply chain efficiency. It focuses on delivering high-quality healthcare solutions through continuous innovation in pharmaceutical manufacturing and formulation technology.

Recent filings

Filing Released Lang Actions
独立董事关于第二届董事会第二十一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion statement from the independent directors of Jiangxi Xinganjiang Pharmaceutical Co., Ltd. regarding a board meeting resolution about an external investment and related party transaction. It includes legal references and confirms the fairness and compliance of the transaction. The document is short (678 characters) and focuses on board/management matters related to company governance and decisions. It is not a full financial report, audit, or earnings release, nor is it a regulatory announcement or voting result. The content fits best under Board/Management Information (MANG) as it relates to board opinions on company decisions.
2023-05-28 Chinese
第二届监事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 14th meeting of the 2nd Supervisory Board of Jiangxi Xinganjiang Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda, and voting results regarding an investment decision. There is no financial report, audit, or detailed financial data presented. The document is a corporate governance announcement related to board/supervisory committee decisions and internal company matters. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not a regulatory filing or a report publication announcement since it contains substantive meeting resolution content. The best fitting category is Board/Management Information (MANG), as it announces board/supervisory meeting resolutions and related governance matters.
2023-05-28 Chinese
2022年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2022 annual equity distribution (dividend) plan of Jiangxi Xinganjiang Pharmaceutical Co., Ltd. It details the dividend amount, payment dates, tax treatment, and record dates. It references the shareholders' meeting approval but does not contain financial statements or detailed financial analysis. The document length is short (1214 characters) and it is clearly an announcement of dividend distribution details rather than a full financial report or annual report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2023-05-23 Chinese
关于完成工商变更登记及公司章程备案并取得营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of business registration changes and company charter filing, including obtaining a new business license. It details corporate administrative updates such as changes in registered capital and company registration information. The document is short (760 characters) and does not contain financial statements or detailed financial data. It is not a report like an Annual Report or Interim Report, nor is it a regulatory certification or legal proceeding. It is a regulatory announcement about corporate registration and administrative changes, which fits best under Regulatory Filings (RNS).
2023-05-22 Chinese
投资者关系活动记录表
Regulatory Filings Classification · 95% confidence The document is an announcement of an investor relations activity record, specifically a participation in a collective investor reception day event organized by regulatory and industry bodies. It includes details about the event, participants, and Q&A with investors. There are no financial statements, no detailed financial data, no audit information, no voting results, no management changes, no earnings highlights, or other report content. The document is short (901 characters) and serves as a communication or update rather than a formal report. It fits best under Regulatory Filings (RNS) as a general regulatory announcement and investor relations update that does not fit other specific categories.
2023-05-22 Chinese
2022 年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as an announcement of the 2022 Annual General Meeting (AGM) resolutions of Jiangxi New Ganjiang Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda items, and voting results on various proposals including the 2022 board work report, independent directors' report, supervisory board report, annual report, financial statements, profit distribution plan, and appointment of auditors. The document is a formal announcement of the decisions made at the AGM rather than the full reports themselves. It includes voting results and legal opinions confirming the validity of the meeting and resolutions. The document length is 4610 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-05-22 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.